Figure 1From: Evaluation of adverse reactions in dogs following intravenous mesenchymal stem cell transplantationFlow cytometry analysis of the MSCs from one dog. The cells were harvested from the 3rd passage and the expression of CD9 and CD 44 were identified. CD 34 (4.69%) and CD45 (5.19%), hematopoietic stem cell markers, were used as negative MSCs marker. CD9 (99.63%) and CD44 (99.39%) were used as MSCs positive markers. Non-staining MSCs were used as controls.Back to article page